Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
170
NCT04088318
A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 9, 2019
Completion: Jun 30, 2024